Insight

The CDC is partnering with private, state, and local public health labs to increase genomic surveillance in the US

Modifying the human gut microbiome could be a new way to regulate blood glucose

Delayed cancer screening due to COVID-19 could mean more cancer-related deaths for years to come

Universal genetic testing could offer a middle ground between guideline-based and population-based testing

Fecal microbiota transplants may offer new hope for a range of difficult-to-treat health conditions

After building a CLIA-certified lab in six weeks, NU has gone on to complete more than 975,000 COVID-19 tests

Low sample volume functional proteomics identifies key inflammatory markers in brain of COVID-19 patient

Single-cell proteomics can predict resistance and enable therapies to combat drug-resistant cell states

Current DTC genetic tests can yield misleading results, but understanding a few key points can help

As research around COVID-19 evolves, so too will the recommendations concerning pregnancy and COVID-19

A handful of studies have found that NIPT can detect unexplained aneuploidies in maternal blood samples not present in the fetus

The ultracold storage needs of the Pfizer-BioNTech COVID-19 vaccine compounds the challenges inherent to vaccinating rural populations

mRNA vaccines employ a novel strategy to stimulate immunity against coronavirus spike proteins

To overcome the challenges of NGS, researchers have turned to third-generation or long-read sequencing technologies

The innovative approach combines histopathology and genomics to create maps of genetic expression throughout a tissue

Next-generation sequencing can identify known and novel genetic mutations that underlie complex neurological disorders

Approaches clinical laboratories can take to reduce diagnostic blood loss

With no clear standards for A1C screening in early pregnancy, researchers focus on establishing useful guidelines

Screening for blood cell mutations can identify those at greater risk for hematologic cancers and cardiovascular disease

Promising results from the first in-human trials of genetically engineered malaria vaccines